Format
Sort by

Send to

Choose Destination

Links from Books

Items: 6

1.

Pretargeted molecular imaging and radioimmunotherapy.

Goldenberg DM, Chang CH, Rossi EA, J W, McBride, Sharkey RM.

Theranostics. 2012;2(5):523-40. doi: 10.7150/thno.3582.

2.

Potential for clinical radionuclide-based imaging and therapy of common cancers expressing EGFR-family receptors.

Carlsson J.

Tumour Biol. 2012 Jun;33(3):653-9. doi: 10.1007/s13277-011-0307-x. Review.

PMID:
22228543
3.

Epidermal growth factor receptors: a functional perspective.

Mitrasinovic PM.

Curr Radiopharm. 2012 Jan;5(1):29-33. Review.

PMID:
22074479
4.

Comparison of bifunctional chelates for (64)Cu antibody imaging.

Ferreira CL, Yapp DT, Crisp S, Sutherland BW, Ng SS, Gleave M, Bensimon C, Jurek P, Kiefer GE.

Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2117-26. doi: 10.1007/s00259-010-1506-1.

PMID:
20552190
5.

Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals.

Ferreira CL, Yapp DT, Lamsa E, Gleave M, Bensimon C, Jurek P, Kiefer GE.

Nucl Med Biol. 2008 Nov;35(8):875-82. doi: 10.1016/j.nucmedbio.2008.09.001.

PMID:
19026949
6.

HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.

Dragowska WH, Warburton C, Yapp DT, Minchinton AI, Hu Y, Waterhouse DN, Gelmon K, Skov K, Woo J, Masin D, Huxham LA, Kyle AH, Bally MB.

Mol Cancer Res. 2004 Nov;2(11):606-19.

Items per page

Supplemental Content

Support Center